top of page
hemotune AG is a spin-off company originating out of the Functional Materials Lab at ETH Zurich.
hemotune was founded in 2017 and so far raised more than CHF 18 million of funds since incorporation.
We envision a future where precision blood purification is an indispensable tool to improve patient outcomes and save lives in critical illness and beyond.
Our mission is to develop breakthrough blood purification technology, enabling revolutionary intervention strategies for the most urgent medical needs and making them accessible for the benefit of patients.
about the company